Detalhe da pesquisa
1.
Phase II consolidation trial with anti-Lewis-Y monoclonal antibody (hu3S193) in platinum-sensitive ovarian cancer after a second remission.
Int J Gynecol Cancer
; 31(4): 562-568, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33664128
2.
An Exploration of the Associations of Alcohol-Related Social Media Use and Message Interpretation Outcomes to Problem Drinking Among College Students.
Health Commun
; 32(7): 864-871, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27421038
3.
A phase II trial with anti-Lewis-Y monoclonal antibody (hu3S193) for the treatment of platinum resistant/refractory ovarian, fallopian tube and primary peritoneal carcinoma.
Gynecol Oncol
; 138(2): 272-7, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26026738
4.
Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma.
Invest New Drugs
; 31(2): 425-34, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22864522
5.
A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen.
Int J Cancer
; 129(12): 2836-46, 2011 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21448901
6.
Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™.
Cancer Immunol Immunother
; 60(11): 1625-37, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21698545
7.
Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming.
Proc Natl Acad Sci U S A
; 105(5): 1650-5, 2008 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-18216244
8.
Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma.
Clin Cancer Res
; 15(6): 2166-73, 2009 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19276262
9.
Analysis of peripheral and local anti-tumor immune response in esophageal cancer patients after NY-ESO-1 protein vaccination.
Int J Cancer
; 123(10): 2362-9, 2008 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18729190
10.
Humoral immune responses in patients vaccinated with 1-146 HER2 protein complexed with cholesteryl pullulan nanogel.
Cancer Sci
; 99(3): 601-7, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18081877
11.
A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen.
Clin Cancer Res
; 13(11): 3286-92, 2007 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17545534
12.
A pilot study of monoclonal antibody cG250 and low dose subcutaneous IL-2 in patients with advanced renal cell carcinoma.
Cancer Immun
; 7: 14, 2007 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-17705350
13.
A phase I multiple dose, dose escalation study of cG250 monoclonal antibody in patients with advanced renal cell carcinoma.
Cancer Immun
; 7: 13, 2007 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-17705349
14.
HER2-specific T-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulan.
Clin Cancer Res
; 12(24): 7397-405, 2006 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17189412
15.
Translation of cancer immunotherapies.
Nat Med
; 10(11): 1154-5; author reply 1155, 2004 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-15516901
16.
Phase I trial of 131I-huA33 in patients with advanced colorectal carcinoma.
Clin Cancer Res
; 11(13): 4818-26, 2005 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16000579
17.
A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer.
Clin Cancer Res
; 9(5): 1639-47, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12738716
18.
Exploring college students' use of general and alcohol-related social media and their associations with alcohol-related behaviors.
J Am Coll Health
; 62(5): 328-35, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24635485
19.
Phase I trial of overlapping long peptides from a tumor self-antigen and poly-ICLC shows rapid induction of integrated immune response in ovarian cancer patients.
Clin Cancer Res
; 18(23): 6497-508, 2012 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23032745
20.
Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient.
Cancer Immunol Immunother
; 57(10): 1429-37, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18311489